NCT03603067

Brief Summary

This study is designed to evaluate the change of psychological status before and after surgery in monophthalmic patients who receive the ocular surgery in eye with better vision.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 7, 2018

Completed
20 days until next milestone

First Posted

Study publicly available on registry

July 27, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

July 27, 2018

Status Verified

June 1, 2018

Enrollment Period

1.5 years

First QC Date

July 7, 2018

Last Update Submit

July 26, 2018

Conditions

Keywords

monophthalmossocial psychologyocular surgery

Outcome Measures

Primary Outcomes (2)

  • Level of anxiety

    Hamilton anxiety scale(HAMA)will be filled in by each patient and the final score will be recorded. The total score ranges from 0-56. A score less than 7 means no symptom of anxiety. A score between 7 to 14 means possible anxiety. A score between 14-21 means mild anxiety. A score between 21-29 means moderate anxiety. A score more than 29 means severe symptom of anxiety.

    Change from Baseline HAMA score at 6 months.

  • Level of depression

    Hamilton depression scale (HAMD) will be filled in by each patient and the final score will be recorded. The total score ranges from 0-56. A score less than 8 means no symptom of depression. A score between 8 to 35 means mild or moderate depression. A score more than 35 means severe symptom of depression.

    Change from Baseline HAMD score at 6 months.

Secondary Outcomes (1)

  • Level of social support

    Change from Baseline SSRS score at 6 months.

Other Outcomes (1)

  • Visual function

    One day before surgery and one day, one months, three months and six months after surgery.

Study Arms (2)

monophthalmic group

The BCVA of the worse eye is less than 0.05 or CFOV is less than 5°. The better eye need to receive ocular surgery.

Procedure: Ocular surgery

Normal group

The BCVA of the worse eye is more than 0.3 and CFOV is more than 10°. One of two eyes need to receive ocular surgery.

Procedure: Ocular surgery

Interventions

Different ocular surgeries (including vitreoretinal surgery, cataract surgery, anti-glaucoma surgery etc) will be performed in one eye of the patient. In monophthalmic patient group the surgery will be performed in eye with better visual acuity.

Normal groupmonophthalmic group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients hospitalized in Shanghai Aier Eye Hospital and are intended to receive ocular surgery in one of two eyes.

You may qualify if:

  • Intention to receive ocular surgery in one of two eyes.
  • Free from prior mental disorders.
  • Without general disease and can tolerate the operation.
  • Communication without difficulty.

You may not qualify if:

  • With prior mental disorders.
  • Can not tolerate the operation.
  • Communication with difficulty.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Aier Eye Hospital

Shanghai, Shanghai Municipality, 200000, China

RECRUITING

Related Publications (1)

  • Hirneiss C, Neubauer AS, Herold TR, Kampik A, Hintschich C. Utility values in patients with acquired anophthalmus. Orbit. 2009;28(6):332-6. doi: 10.3109/01676830903104702.

    PMID: 19929654BACKGROUND

MeSH Terms

Conditions

cyclopia sequence

Interventions

Ophthalmologic Surgical Procedures

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Study Officials

  • Wensheng Li

    Shanghai Aier Eye Hospital

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2018

First Posted

July 27, 2018

Study Start

January 1, 2018

Primary Completion

June 30, 2019

Study Completion

December 31, 2019

Last Updated

July 27, 2018

Record last verified: 2018-06

Locations